These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1548412)

  • 1. Failure of the 12 months course of antituberculous chemoprophylaxis in HIV infection.
    Di Perri G; Vento S; Cruciani M; Marocco S; Mazzi R; Concia E; Bassetti D
    J Infect; 1992 Jan; 24(1):108-9. PubMed ID: 1548412
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and long-term efficacy of antituberculous treatment in HIV-seropositive patients with tuberculosis: a study of 36 cases.
    Schürmann D; Bergmann F; Jautzke G; Fehrenbach J; Mauch H; Ruf B
    J Infect; 1993 Jan; 26(1):45-54. PubMed ID: 8454888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculous psoas muscle abscess following chemoprophylaxis with isoniazid in a patient with human immunodeficiency virus infection.
    Johnson SC; Stamm CP; Hicks CB
    Rev Infect Dis; 1990; 12(5):754-6. PubMed ID: 2237113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprophylaxis for tuberculosis.
    Israel HL
    Respir Med; 1993 Feb; 87(2):81-3. PubMed ID: 8497689
    [No Abstract]   [Full Text] [Related]  

  • 5. Relapse of tuberculosis in a patient with the acquired immunodeficiency syndrome despite 12 months of antituberculous therapy and continuation of isoniazid.
    Shafer RW; Jones WD
    Tubercle; 1991 Jun; 72(2):149-51. PubMed ID: 1949219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are microbiological studies necessary before starting tuberculosis chemoprophylaxis?].
    Barrasa Villar JI; Guimbao Bescós J; Gotor Lázaro G; Aspíroz Sancho C
    Med Clin (Barc); 1995 Oct; 105(14):559. PubMed ID: 8523937
    [No Abstract]   [Full Text] [Related]  

  • 7. Tuberculosis chemoprophylaxis.
    Salpeter S
    West J Med; 1992 Oct; 157(4):421-4. PubMed ID: 1462535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and HIV infection.
    Malone JL; Paparello SF; Malone JD; Hill HE; Myers JW; Weiss P
    Lancet; 1993 Sep; 342(8872):677. PubMed ID: 8103159
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of the HIV epidemic on tuberculosis control programmes in developing countries.
    Veeken H; Bermejo A
    Trop Doct; 1992 Apr; 22(2):64-7. PubMed ID: 1344023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
    Small PM; Schecter GF; Goodman PC; Sande MA; Chaisson RE; Hopewell PC
    N Engl J Med; 1991 Jan; 324(5):289-94. PubMed ID: 1898769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection: the dominant new face of tuberculosis.
    Reichman LB
    Mt Sinai J Med; 1992 May; 59(3):271-7. PubMed ID: 1603117
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant tuberculosis.
    Snider DE; Cauthen GM; Farer LS; Kelly GD; Kilburn JO; Good RC; Dooley SW
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):732. PubMed ID: 1909847
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of disseminated tuberculosis and acquired immunodeficiency syndrome in an 81-y-old woman.
    Laszlo A; Gianelli S; Laurencet F; Krause KH; Janssens JP
    Scand J Infect Dis; 2003; 35(6-7):420-2. PubMed ID: 12953961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis and HIV infection: study of 50 cases].
    Laguna Cuesta F; Chimeno Herrero CP; García Aguado C; Martínez Fernández R; González Lahoz J; Ortega Calderón A
    Rev Clin Esp; 1989 Mar; 184(5):230-3. PubMed ID: 2505338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycobacterial infection in patients with AIDS].
    Zalewska-Schöntaler N; Zajaczkowska J; Kamińska E; Babiuch L
    Pneumonol Alergol Pol; 1993; 61(5-6):287-90. PubMed ID: 8348094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Human immunodeficiency virus infection and tuberculosis: who should receive chemoprophylaxis?].
    Moreno Guillén S
    Rev Clin Esp; 1994 Feb; 194(2):73-4. PubMed ID: 8008942
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature.
    Barber TW; Craven DE; McCabe WR
    Medicine (Baltimore); 1990 Nov; 69(6):375-83. PubMed ID: 2122171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid prophylaxis in end-stage renal disease.
    Bal AM
    Transpl Infect Dis; 2006 Dec; 8(4):242-3; author reply 243. PubMed ID: 17116141
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.